SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SYNTHETECH - NZYM -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (326)5/10/2000 3:59:00 PM
From: Dan Gibbs  Read Replies (1) | Respond to of 372
 
Tuck,

I don't think NZYM would be supplying anything for antisense nucleotide drugs as these are more similar to nucleic acids (like DNA and RNA) than peptides. Still, I understand there is a good pipeline of peptide and small molecule drugs making their various ways through the late clinical stages. Sooner or later some of these will get approved and provide a boost to NZYM. Patience...

Dan


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News